The anti-cocaine vaccine, developed by researchers at the Federal University of Minas Gerais, Brazil, aims to produce antibodies that bind to cocaine when it is taken. This would make it harder for the substance to pass through the bloodstream to the brain. The vaccine would try to inhibit the brain reactions that trigger the craving.
Latest News
13:27
EU negotiations on military mobility are advancing on cooperation with Ukraine and Moldova, but the final agreement remains open
13:21
Haas replaces Esteban Ocon with Rafael Câmara at the Brazilian Grand Prix, Formula 1
13:20
The Agency for Payments and Intervention in Agriculture transfers €164.7 million to 34,992 farmers in the new tranche of advance payments for the 2026 Campaign
13:19
Pedro Sánchez welcomes the U.S. election results and announces the progressive comeback
13:15
Politico: The European Union asks Ukraine to accelerate reforms and sets a more cautious path toward accession
See more news